Novoxel – Forward in Motion

Novoxel is a medical technology company founded in 2011 and based in Israel, with a facility in Tennessee. The company specializes in innovative treatments for fractional skin rejuvenation and ophthalmology, utilizing its proprietary thermo-mechanical action (TMA) technology. Novoxel aims to enhance aesthetic and medical treatments by combining heat and motion in a non-laser, patient-friendly approach that is safe and effective. The company develops and markets patented medical devices in over 30 countries. Its flagship product, the Tixel® Platform, offers fractional skin resurfacing for various body areas, providing quick, non-invasive treatments with minimal downtime. The Tixel i® Device, recently FDA-cleared, treats evaporative dry eye by applying localized heat and pressure to the eyelids. Novoxel targets medical professionals, including dermatologists and ophthalmologists, and collaborates with the medical community to ensure clinical excellence and innovation.

• Employees 30